Lacosamide Solution
Product Images NDC 31722-627

11 FDA label images from Camber Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 31722-627). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lacosamideosstructure (Lacosamideosstructure)

Lacosamideosstructure (Lacosamideosstructure)
Chemical structure of Lacosamide, showing the molecular arrangement including an acetyl group, methoxy group, amide bonds, and a phenyl ring.*
FDA Label Image

Lacosamideosfigure1 (Lacosamideosfigure1)

Lacosamideosfigure1 (Lacosamideosfigure1)
A bar chart depicting seizure reduction percentages in adults with partial-onset seizures in studies 2, 3, and 4. The x-axis shows groups receiving placebo or lacosamide at specified dosages (mg/d), while the y-axis represents seizure reduction percentages. Lacosamide-treated groups show higher seizure reduction compared to placebo across studies.*
FDA Label Image

Lacosamideosfigure2 (Lacosamideosfigure2)

Lacosamideosfigure2 (Lacosamideosfigure2)
This is a line chart comparing the responder rate over percent of patients for Lacosamide oral solution at doses 200 mg/day, 400 mg/day, and 600 mg/day versus placebo. The y-axis shows responder rate (equal to or greater improvement), and the x-axis shows percent of patients, with lines illustrating different dose responses.*
FDA Label Image

Lacosamideosfigure3 (Lacosamideosfigure3)

Lacosamideosfigure3 (Lacosamideosfigure3)
A Kaplan-Meier survival curve chart showing the proportion of patients over time (days) for two groups: Lacosamide (n=118) and Placebo (n=121). The chart compares patient outcomes over approximately 170 days, including a risk table below the x-axis listing numbers at risk for Lacosamide and Placebo at various time points. Statistical values such as p-value, hazard ratio (HR=0.548), risk reduction (45.2%), and 95% confidence interval are noted on the chart.*
FDA Label Image

Lacosamideoscamberlogo1 (Lacosamideoscamberlogo1)

FDA Label Image

Lacosamideos200mlcontlabel (Lacosamideos200mlcontlabel)

Lacosamideos200mlcontlabel (Lacosamideos200mlcontlabel)
Label for Lacosamide Oral Solution 10 mg/mL by Camber Pharmaceuticals, Inc. The label indicates a 200 mL oral solution with a storage temperature range and dosing instructions reference. It includes NDC 31722-627-26 and pharmacist attention notes. The label also shows manufacturing information and a barcode.*
FDA Label Image

Lacosamideos465mlcontlabel (Lacosamideos465mlcontlabel)

Lacosamideos465mlcontlabel (Lacosamideos465mlcontlabel)
Label for Lacosamide Oral Solution, USP, 10 mg/mL by Camber Pharmaceuticals, Inc. The oral solution is contained in a 465 mL bottle. The label includes dosing and storage instructions, barcode, and manufacturing information by Hetero Labs Limited in India, distributed by Camber Pharmaceuticals in Piscataway, NJ.*
FDA Label Image

Lacosamideos200mlcartonlabel (Lacosamideos200mlcartonlabel)

Lacosamideos200mlcartonlabel (Lacosamideos200mlcartonlabel)
Packaging label for Lacosamide Oral Solution USP 10 mg/mL by Camber Pharmaceuticals, Inc. The label includes dosing information, storage instructions, and safety warnings. The product is supplied in a 200 mL bottle with NDC 31722-627-26. The label features a barcode and manufacturing details from Hetero Labs Limited, India.*
FDA Label Image

Lacosamideos465mlcartonlabel (Lacosamideos465mlcartonlabel)

Lacosamideos465mlcartonlabel (Lacosamideos465mlcartonlabel)
Packaging label for Lacosamide Oral Solution, USP 10 mg/mL by Camber Pharmaceuticals, Inc. Label shows 465 mL bottle size and states the active ingredient concentration. Includes manufacturer information for Camber Pharmaceuticals in Piscataway, NJ, with secondary manufacturer Hetero Labs Limited, India. The label also provides storage instructions, pharmacist attention notice, and a medication guide URL.*
FDA Label Image

Lacosamideoscontainerlabelannora (Lacosamideoscontainerlabelannora)

Lacosamideoscontainerlabelannora (Lacosamideoscontainerlabelannora)
Label for Lacosamide Oral Solution, USP 10 mg/mL by Camber Pharmaceuticals, Inc. The 200 mL bottle label includes storage instructions, pharmacist attention notice, usage warnings, and manufacturer contact information. The label also features a barcode and batch information, with emphasis on dosage concentration and prescription status.*
FDA Label Image

Lacosamideoscontainercartonlabelannora (Lacosamideoscontainercartonlabelannora)

Lacosamideoscontainercartonlabelannora (Lacosamideoscontainercartonlabelannora)
Packaging label for Lacosamide Oral Solution, USP 10 mg/mL by Camber Pharmaceuticals, Inc. The label indicates a 200 mL oral solution with a NDC of 31722-627-26. It includes storage instructions, phenylketonuric content information, pharmacist attention notice, and manufacturer details for Camber Pharmaceuticals, Piscataway, NJ. The design features the Camber logo, dosage strength in a red box, and regulatory and contact information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.